InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Perry Andrew, Directeur Commercial. Insider active across 1 company, notably G1 Therapeutics, Inc.. Aggregated, 9 filings have been logged. Split: 0 buy · 3 sells. Total volume traded: €40k. History available since 3 January 2022. The latest transaction was filed on 5 July 2024 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Perry Andrew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
16,100 sharesCommon StockSEC:0000950170-24-107787:0
1,337 shares@ US$2.50777.7% of flowCommon StockSEC:0001562180-24-005660:0
35,000 shares0Common StockSEC:0001562180-24-005608:0
8,151 shares@ US$4.788890.3% of flowCommon StockSEC:0001562180-24-004064:0
33,570 shares0Common StockSEC:0001562180-24-000325:0
355 shares@ US$2.45372.0% of flowCommon StockSEC:0001562180-23-005819:0
35,000 shares0Common StockSEC:0001562180-23-004095:0
16,100 shares0Common StockSEC:0001562180-23-000253:0
6,000 shares0Common StockSEC:0001562180-22-000308:0
9 of 9 declarations
About Perry Andrew
Perry Andrew is Directeur Commercial and Chief Commercial Officer at G1 Therapeutics, Inc. Across 9 filings, the 9 sampled filings cover the period from 2022-01-05 to 2024-09-18, with EUR 0 in buys and EUR 40067 in sells.
